Terrence L. Stull, M.D., is President of BacVax. He is responsible for the administrative and scientific direction of BacVax’s development of Bacterial Vaccine Polypeptides. His education and training include his M.D. from the University of Birmingham in Alabama, residency training at Stanford, and Pediatric Infectious Diseases training at the University of Washington. He practiced medicine for >30 years, and he led an NIH-funded research team focused on H. influenzae pathogenesis for >25 years. Dr. Stull was Chairman of the Department of Pediatrics at the University of Oklahoma Health Sciences Center for 22 years with annual operating budget growth from $15 Million to $120 Million. Most recently he led the administration of over 500 clinical research studies as the Senior Vice-President of Research at Phoenix Children’s Hospital. He is also a professor at the University of Arizona College of Medicine Phoenix, where he oversaw the research that resulted in the Bacterial Vaccine Polypeptide platform.